Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ion transporters are integral membrane proteins that facilitate the movement of ions across biological membranes, typically against their electrochemical gradients (NCBI, 2023). This process is essential for maintaining cellular homeostasis, including the regulation of intracellular pH, cell volume, and the resting membrane potential (UniProt, 2024). Unlike ion channels, which allow for passive diffusion, ion transporters often require energy, either directly from ATP hydrolysis or indirectly through the coupling of ion gradients (Molecular Biology of the Cell, 2014). They are classified into various families, such as P-type ATPases and the solute carrier (SLC) group, each with specific substrate preferences and physiological roles. Dysregulation of these transporters is implicated in numerous diseases, including hypertension, cystic fibrosis, and various neurological disorders (PubMed, 2022). Consequently, they serve as vital therapeutic targets; for instance, proton pump inhibitors target the H+/K+-ATPase to treat gastric ulcers, while loop diuretics inhibit the Na-K-Cl cotransporter in the kidneys to manage edema and hypertension (StatPearls, 2023). Pharmacological modulation of these proteins allows for precise control over ionic environments, making them indispensable in modern medicine. Research continues to uncover the roles of specific transporter isoforms in complex diseases like cancer and neurodegeneration.
Drugs targeting ion transporters typically function through the inhibition of primary active transport (e.g., ATPases) or secondary active transport (e.g., cotransporters and exchangers) by binding to specific sites on the protein, thereby preventing ion translocation and altering physiological ion gradients (StatPearls, 2023; PubMed, 2021).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ion transporter.